Deliver An Omnichannel Experience With Medical Affairs Global Content Strategies

Reach your audience faster in a conceptually equivalent, culturally appropriate and compliant way.

Learn more
Healthcare global with hand reaching out to connect

Customer-centric focus to effectively engage and educate key stakeholders, no matter the language

Increasingly specialty medicine requires increasingly specialized education. The methods to deliver digital content are multiplying. The way physicians consume medical content is evolving. All of the above create complexity for medical affairs teams trying to deliver high-quality, engaging content.

With 30+ years of experience, TransPerfect Life Sciences helps MedAffairs teams adapt their communications to effectively reach patients, sponsors, CROs, HCPs, and the general public in compliance with local regulations.

patient engagement in clinical R&D

Evolve Your Medical Affairs Operations From a Regional to a Global Integrated Model

With our expert localization and content adaption service for medical affairs teams, we have helped them see a reduction in content development costs by over 25%.

Why Choose TransPerfect Life Sciences for your Medical Affairs Content Creation and Adaption?

  • >25% Reduction in Content Development Costs
  • Future-Proof Scalability with Technology Driven Workflows and Integrations
  • Flexible and Customizable
  • Fully Integrated Model With Knowledge Management Systems and Processes

Even simple changes to the language of medical affairs content can significantly impact the effectiveness of global messaging.

We make sure your communications relay exactly what you mean, regardless of who you’re speaking to.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

LifeSci Talks COA Series | Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, to discuss whether the field of clinical outcome assessment has started sacrificing “good for perfect.” Together, they explore the role of regulatory guidance and clinical development timelines, specifically the role of measurement science in already tight development ...

LifeSci Talks COA Series | Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?

C3 Summit 2025 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

Libraries in Clinical Outcome Assessments: How Valuable Are They—and Are They the Panacea They’re Claimed to Be?

Speed, cost, and quality are competing priorities in eCOA localization. Discover why translation libraries alone aren't enough, and what combination of proactive licensing, automation, and integrated technology can transform your deployment timelines. ...

From Reactive to Strategic: How AI Is Transforming Medical Information Contact Centers

IntroductionFor decades, Medical Information (MI) has been an essential function within pharma, but largely a reactive one. This is especially true in medical information contact centers, which serve as the first line of support for HCPs and patients. When someone has a...

Is AI Ready to Transform COA Development?

AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover...

Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them

In a recent "LifeSci Talks" episode, TransPerfect Global Practice Leader Mark Wade and Signant Health VP and eCOA Scientist Bill Byrom PhD discussed how new FDA guidance is reshaping how sponsors approach patient-reported outcomes (PROs) in cancer clinical trials. PROs...

AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...

Interested in learning how we can help your Medical Affairs content strategies?